메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기
Huons Global
Huons
Humedix
HuM&C
Huons BioPharma
Huons Meditech
Huonslab
Food Assemble
Huons USA
Huons Japan
HuonsLifeSciences
Huons N
Bio Rosette
주메뉴
Company
Overview
History
CI
Executives
Vision
Location
Products
Biologics
CDMO Service
Reagents
R&D
Core Technology
Pipeline
Achievements
Investor
Stock information
Disclosures information
Financial information
IR News
Customer
Contact
Online Inquiry
언어선택
KOR
ENG
Company
Overview
History
CI
Executives
Vision
Location
Products
Biologics
CDMO Service
Reagents
R&D
Core Technology
Pipeline
Achievements
Investor
Stock information
Disclosures information
Financial information
IR News
Customer
Contact
Online Inquiry
KOR
ENG
Company
Overview
History
CI
Executives
Vision
Location
Products
Biologics
CDMO Service
Reagents
R&D
Core Technology
Pipeline
Achievements
Investor
Stock information
Disclosures information
Financial information
IR News
Customer
Contact
Online Inquiry
Investor
INVESTOR
Stock information
Disclosures information
Financial information
IR News
IR News
전체
Notice
IR Book
No
Subject
Writer
Date
6
[Notice] PanGen Biotech Announces FY2025 Results, Revenue of KRW 13.42 Billion, Operating Profit at 1.51 Billion
팬젠
26-02-03
5
[Notice] Three Affiliates of Huons Group Honored with Export Tower Awards on Trade Day
팬젠
25-12-09
4
[Notice] PanGen Biotech Reports Q3 2025 Results, Cumulative Sales of 10.94 Billion Won, Operating Profit of 1.91 Billion Won
팬젠
25-11-13
3
[Notice] PanGen Biotech to Renew its GMP Certification in Turkiye
팬젠
25-09-25
2
[Notice] PanGen Biotech Reports Q2 2025 Financial Results with 3.49 Billion won in Revenue and 833 million won in Profit
팬젠
25-08-13
1
[Notice] PanGen posts Q1 sales of 3.4 billion won and operating profit of 700 million won
팬젠
25-05-14